Aether Therapeutics Inc.

10/01/2026 | Press release | Distributed by Public on 10/01/2026 15:19

Annual Report by Private Issuer (Form C-AR)

FORM C UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
OMB APPROVAL


FORM C-AR

OMB Number: ####-####

Estimated average burden hours per response: ##.#

Form C: Filer Information

Filer CIK:
0002004745
Filer CCC:
XXXXXXXX
Period:
12-31-2025


Is this a LIVE or TEST Filing? LIVE TEST
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption?
Would you like a Return Copy?

Submission Contact Information

Name:
Phone Number:
Contact E-Mail Address:
Notify via Filing Website only?

Form C: Issuer Information

Issuer Information

Name of Issuer:
Aether Therapeutics Inc.


Legal Status of Issuer:

Form:
Corporation


Jurisdiction of Incorporation/Organization:
DELAWARE


Date of Incorporation/Organization:
12-19-2017


Physical Address of Issuer:

Address 1:
4200 MARATHON BLVD


Address 2:
STE 200


City:
AUSTIN


State/Country:
TEXAS


Mailing Zip/Postal Code:
78756


Website of Issuer:
http://www.aethertherapeutics.com/


Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:
2.00


Total Assets Most Recent Fiscal Year-end:
75756.21


Total Assets Prior Fiscal Year-end:
9609.77


Cash and Cash Equivalents Most Recent Fiscal Year-end:
63792.22


Cash and Cash Equivalents Prior Fiscal Year-end:
9067.12


Accounts Receivable Most Recent Fiscal Year-end:
0.00


Accounts Receivable Prior Fiscal Year-end:
0.00


Short-term Debt Most Recent Fiscal Year-end:
404976.98


Short-term Debt Prior Fiscal Year-end:
0.00


Long-term Debt Most Recent Fiscal Year-end:
0.00


Long-term Debt Prior Fiscal Year-end:
115000.00


Revenue/Sales Most Recent Fiscal Year-end:
0.00


Revenue/Sales Prior Fiscal Year-end:
0.00


Cost of Goods Sold Most Recent Fiscal Year-end:
0.00


Cost of Goods Sold Prior Fiscal Year-end:
0.00


Taxes Paid Most Recent Fiscal Year-end:
0.00


Taxes Paid Prior Fiscal Year-end:
0.00


Net Income Most Recent Fiscal Year-end:
-580436.20


Net Income Prior Fiscal Year-end:
-1070791.24


Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.
Issuer:
Aether Therapeutics Inc.


Signature:
Enter these top to bottom, matching the signed authorization. Issuer: Keep Aether Therapeutics Inc. Signature: Aaron Schuchart


Title:
Principal Executive Officer


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
Aaron Schuchart


Title:
Principal Executive Officer


Date:
08-03-2026


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
Aaron Schuchart


Title:
Principal Financial Officer


Date:
08-03-2026


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
Aaron Schuchart


Title:
Controller or Principal Accounting Officer


Date:
08-03-2026


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
Richard Hawkins


Title:
Board Member


Date:
08-03-2026


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
Jon Saxe


Title:
Board Member


Date:
08-03-2026


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
John Harris


Title:
Board Member


Date:
08-03-2026


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
Wolfgang Sadee


Title:
Board Member


Date:
08-03-2026


Aether Therapeutics Inc. published this content on October 01, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on October 01, 2026 at 21:19 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]